Why Exelixis Stock Trounced the Market on Thursday
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Cancer drug specialist Exelixis (NASDAQ: EXEL) was quite the stock market star on Friday. Following news that it’s making a big, shareholder-pleasing move, market players piled into the company to push its shares 5% higher on the day. This provided some light in what was generall
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2164244046-64f9853c96bb46f78938aaecb5dd7b42.jpg "<div>How Do I Find a Stock's Number of Shorted Shares?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1140306256-b33cd37a3a43400e917a2b551db24bb7.jpg "Instagram: What It Is, Its History, and How the Popular App Works")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1490883641-068d56e8e8ef41d9b756c6d4d9c46760.jpg)
" title="